Helix Announces Initiation of First Clinical Site for US Study - Seite 3
Forward-looking statements and information are based on the beliefs, assumptions and expectations of Helix's management on the date of this news release, and Helix does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions or expectations, or other circumstances change, except as required by law.
Lesen Sie auch
Investor Relations:
Helix BioPharma Corp.
Tel: (905) 841-2300
Email: ir@helixbiopharma.com
Aktuelle Themen
1 im Artikel enthaltener WertIm Artikel enthaltene Werte